Quick Answer
KIORA PHARMACEUTICALS INC reported Common Stock Shares Outstanding of 3.76 million shares for the year ending 2025.
- KIORA PHARMACEUTICALS INC showed an increase of +25.4% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from KIORA PHARMACEUTICALS INC's annual report (Form 10-K), filed with the SEC on March 25, 2026.
- XBRL data for this metric is available from 2015 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 13 years of available data (2015 to 2025), KIORA PHARMACEUTICALS INC's Common Stock Shares Outstanding has declined by 50.9%.
- Historical annual values: Fiscal year 2025: 3.76 million shares | Fiscal year 2024: 3.00 million shares | Fiscal year 2024: 26.74 million shares | Fiscal year 2023: 856,182 shares | Fiscal year 2022: 1.80 million shares | Fiscal year 2022: 1.08 million shares | Fiscal year 2021: 316,599 shares | Fiscal year 2020: 5.56 million shares | Fiscal year 2019: 4.08 million shares | Fiscal year 2018: 3.04 million shares | Fiscal year 2017: 17.26 million shares | Fiscal year 2016: 10.13 million shares | Fiscal year 2015: 7.66 million shares.
- Data sourced from SEC EDGAR public filings as of June 24, 2026.
Last verified: